Torsten Falk, Ph.D.

Cellular and rodent models to test novel pharmacological treatments for levodopa-induced dyskinesias, a major side effect of Parkinson’s disease treatment, as well as new neuroprotective gene and drug therapy approaches to Parkinson’s disease